VYNE Therapeutics
VYNE
$2.77
Share price
2.59%
Change (1 day)
-61.42%
Change (1 year)
Categories
Earnings for VYNE Therapeutics (VYNE)
Earnings in 2023 (TTM): -$29.26 M
According to VYNE Therapeutics's latest financial reports the company's current earnings (TTM) are -$29.26 M. In 2022 the company made an earning of -$34.06 M an increase over its 2021 earnings that were of -$42.25 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for VYNE Therapeutics from 2017 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$29.26 M | -14.09% |
| 2022 | -$34.06 M | -19.38% |
| 2021 | -$42.25 M | -83.2% |
| 2020 | -$0.26 B | 229.89% |
| 2019 | -$76.25 M | 39.8% |
| 2018 | -$54.54 M | 84.29% |
| 2017 | -$29.6 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.12 B | 278.62% | 🇺🇸 USA |